Understanding and Communicating Measures of Treatment Effect on Survival: Can We Do Better?

Time-to-event end points are the most frequent primary end points in phase III oncology trials, both in the adjuvant and advanced settings. The evaluation of these end points is important to inform clinical practice. However, although different measures can be used to describe the effect of treatmen...

Celý popis

Podrobná bibliografia

Vydané v:	JNCI : Journal of the National Cancer Institute Ročník 110; číslo 3; s. 232
Hlavní autori:	Saad, Everardo D, Zalcberg, John R, Péron, Julien, Coart, Elisabeth, Burzykowski, Tomasz, Buyse, Marc
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.03.2018
Predmet:	Clinical Trials as Topic - standards Humans Neoplasms - mortality Neoplasms - therapy Outcome Assessment (Health Care) - standards Prognosis Research Design - standards Survival Rate
ISSN:	1460-2105, 1460-2105
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!